Epoetin Beta Therapeutics Market Is Expected to Expand at an Impressive Rate by 2025
Erythropoietin is a hormone released from the kidneys. Erythropoietin protein is responsible for the development of red blood cells (RBCs) in the body. Increase in the number of RBCs raises the level of hemoglobin in the blood, which is the substance responsible for transport of oxygen to every part of the body. Epoetin beta is one of the three erythropoiesis-stimulating agents available in the Epoetin Beta Therapeutics Market. It is used for the treatment of anemia in patients with severe...
View full press release